# Contact Script Wolverine: The BPC-157 TB-500 Editorial Listing

> Contact Script Wolverine, the independent editorial listing of the BPC-157 TB-500 research record. Editorial correspondence and corrections only — no clinical or sales inquiries.

For corrections, citation questions, and editorial correspondence about the BPC-157 TB-500 record.

## Editorial correspondence

Script Wolverine is an editorial project covering the BPC-157 TB-500 research record. The form below is for editorial correspondence: corrections to a cited figure, questions about a source, or a study you think belongs in the listing. We read every message that engages with the literature.

What we cannot help with: this is not a clinic, a pharmacy, or a vendor. We do not provide medical or legal advice, we do not write or fill prescriptions, we do not arrange compounding or access, and we do not sell or supply BPC-157, TB-500, or any blend. Messages asking us to do any of those things will not receive a substantive reply, because doing them is outside what this site is.

## Corrections and sourcing

If you have found an error, the most useful message points to the specific entry and the primary source that corrects it — a DOI, PMID, or FDA page. Because every claim here is tied to a numbered citation, corrections that cite the record can be checked and filed quickly. We would rather fix a number than defend one.

---

A curated property-portal listing of the BPC-157 TB-500 record — each constituent finding, dose parameter, and FDA 503A access mark filed as its own cited entry, with no clinic, pharmacy, or prescription behind the keyline.